✦ LIBER ✦

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

Book ID: 116317169
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 123 KB
Volume: 47
Category: Article
ISSN: 0266-4356
DOI: 10.1016/j.bjoms.2009.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate endpoints for overall survival

✍ Stefan Michiels; Aurélie Le Maître; Marc Buyse; Tomasz Burzykowski; Emilie Maill 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 349 KB

Locally advanced head and neck cancer: m

Locally advanced head and neck cancer: meta-analysis of updated individual data

✍ J.P. Pignon; B. Baujat; C. Hill; J. Bourhis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Determining surrogate endpoints predicti

Determining surrogate endpoints predictive of overall survival in patients treated with bevacizumab for advanced ovarian cancer — A multi-institutional study

✍ S. Ueda; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; R. Previs; L. Perry; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Neoadjuvant chemotherapy for locally adv

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 373 KB

Chemotherapy added to locoregional treat

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer

✍ J.P Pignon; J Bourhis; C Domenge; L Designe 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 20 KB

Long-term survival of resectable subset

Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer

✍ Yo-Han Cho; Se Hoon Lee; Dong-Wan Kim; Hong-Gyun Wu; J. Hun Hah; Chae-Seo Rhee; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

## Abstract ## Background. Although meta‐analysis showed that survival improved with concurrent chemoradiation in locally advanced head and neck cancer, neoadjuvant chemotherapy is still unique, because it renders curative surgery feasible for marginally resectable head and neck cancer patients.